Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Millipore, a provider of technologies, tools and services for the life science industry and biopharmaceutical manufacturers, has launched a new ProRes-S media as an add on to the company' purification suite, to provide a complete solution for the downstream purification of monoclonal antibodies and proteins.
Subscribe to our email newsletter
Millipore claimed that ProRes-S media offers biopharmaceutical manufacturers flexibility and increased throughput in a smaller manufacturing footprint.
Millipore has developed ProRes-S media, jointly with The Dow Chemical Company.
Additionally, ProRes-S media, a semirigid cation exchange resin, also offers an operating window over a wider range of conductivities which is optimised for resolving difficult impurities and allows higher bed packing.
Paul Chapman, vice president of downstream processing business unit at Millipore, said: “Combining Millipore’s expertise in purification with Dow’s experience in ion-exchange resins technology allows us to offer biopharmaceutical manufacturers an expanded chromatography solution.
“ProRes-S media brings the biomanufacturing industry increased efficiencies to their purification process.”